NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS

NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS

There is provided pharmaceutical formulations that may be used topically comprising a leukotriene receptor antagonist, a salt or a solvate thereof. Particular leukotriene receptor antagonists that may be mentioned include montelukast styrene. The formulations find particular utility in direct topica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: SAMUELSSON, Bengt Ingemar
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SAMUELSSON, Bengt Ingemar
description There is provided pharmaceutical formulations that may be used topically comprising a leukotriene receptor antagonist, a salt or a solvate thereof. Particular leukotriene receptor antagonists that may be mentioned include montelukast styrene. The formulations find particular utility in direct topical administration for the treatment of inflammation, of inflammatory disorders and/or of condition characterized by inflammation, including wounds, burns, psoriasis, haemorrhoids, acne and atopic dermatitis.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3908284A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3908284A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3908284A13</originalsourceid><addsrcrecordid>eNrjZLDxcw1XcPMP8g31cQzx9PcLVnD29wtx9PTz9HNX8HEN9fYPCfJ09XNVCHJ1dg0I8Q9ScARKu_v7eQaHBPMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXAGNLAwsjCxNHQ2MilAAA_3Mp3A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS</title><source>esp@cenet</source><creator>SAMUELSSON, Bengt Ingemar</creator><creatorcontrib>SAMUELSSON, Bengt Ingemar</creatorcontrib><description>There is provided pharmaceutical formulations that may be used topically comprising a leukotriene receptor antagonist, a salt or a solvate thereof. Particular leukotriene receptor antagonists that may be mentioned include montelukast styrene. The formulations find particular utility in direct topical administration for the treatment of inflammation, of inflammatory disorders and/or of condition characterized by inflammation, including wounds, burns, psoriasis, haemorrhoids, acne and atopic dermatitis.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211117&amp;DB=EPODOC&amp;CC=EP&amp;NR=3908284A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211117&amp;DB=EPODOC&amp;CC=EP&amp;NR=3908284A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SAMUELSSON, Bengt Ingemar</creatorcontrib><title>NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS</title><description>There is provided pharmaceutical formulations that may be used topically comprising a leukotriene receptor antagonist, a salt or a solvate thereof. Particular leukotriene receptor antagonists that may be mentioned include montelukast styrene. The formulations find particular utility in direct topical administration for the treatment of inflammation, of inflammatory disorders and/or of condition characterized by inflammation, including wounds, burns, psoriasis, haemorrhoids, acne and atopic dermatitis.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDxcw1XcPMP8g31cQzx9PcLVnD29wtx9PTz9HNX8HEN9fYPCfJ09XNVCHJ1dg0I8Q9ScARKu_v7eQaHBPMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXAGNLAwsjCxNHQ2MilAAA_3Mp3A</recordid><startdate>20211117</startdate><enddate>20211117</enddate><creator>SAMUELSSON, Bengt Ingemar</creator><scope>EVB</scope></search><sort><creationdate>20211117</creationdate><title>NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS</title><author>SAMUELSSON, Bengt Ingemar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3908284A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SAMUELSSON, Bengt Ingemar</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SAMUELSSON, Bengt Ingemar</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS</title><date>2021-11-17</date><risdate>2021</risdate><abstract>There is provided pharmaceutical formulations that may be used topically comprising a leukotriene receptor antagonist, a salt or a solvate thereof. Particular leukotriene receptor antagonists that may be mentioned include montelukast styrene. The formulations find particular utility in direct topical administration for the treatment of inflammation, of inflammatory disorders and/or of condition characterized by inflammation, including wounds, burns, psoriasis, haemorrhoids, acne and atopic dermatitis.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3908284A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T21%3A13%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SAMUELSSON,%20Bengt%20Ingemar&rft.date=2021-11-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3908284A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true